These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10885465)
1. Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum. Kiss T; Kiss E; Garribba E; Sakurai H J Inorg Biochem; 2000 May; 80(1-2):65-73. PubMed ID: 10885465 [TBL] [Abstract][Full Text] [Related]
2. Chemical speciation of insulinomimetic VO(IV) complexes of pyridine-N-oxide derivatives: binary and ternary systems. Kiss E; Kawabe K; Tamura A; Jakusch T; Sakurai H; Kiss T J Inorg Biochem; 2003 Jun; 95(2-3):69-76. PubMed ID: 12763650 [TBL] [Abstract][Full Text] [Related]
3. Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands. Kiss E; Garribba E; Micera G; Kiss T; Sakurai H J Inorg Biochem; 2000 Jan; 78(2):97-108. PubMed ID: 10766332 [TBL] [Abstract][Full Text] [Related]
4. Speciation of potential anti-diabetic vanadium complexes in real serum samples. Sanna D; Ugone V; Serra M; Garribba E J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214 [TBL] [Abstract][Full Text] [Related]
5. A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds. Sanna D; Buglyó P; Micera G; Garribba E J Biol Inorg Chem; 2010 Aug; 15(6):825-39. PubMed ID: 20339887 [TBL] [Abstract][Full Text] [Related]
6. A new family of insulin-mimetic vanadium complexes derived from 5-carboalkoxypicolinates. Gätjens J; Meier B; Kiss T; Nagy EM; Buglyó P; Sakurai H; Kawabe K; Rehder D Chemistry; 2003 Oct; 9(20):4924-35. PubMed ID: 14562311 [TBL] [Abstract][Full Text] [Related]
7. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies. Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973 [TBL] [Abstract][Full Text] [Related]
8. Aminoacid-derivatised picolinato-oxidovanadium(IV) complexes: characterisation, speciation and ex vivo insulin-mimetic potential. Esbak H; Enyedy EA; Kiss T; Yoshikawa Y; Sakurai H; Garribba E; Rehder D J Inorg Biochem; 2009 Apr; 103(4):590-600. PubMed ID: 19121544 [TBL] [Abstract][Full Text] [Related]
9. New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum. Sanna D; Micera G; Garribba E Inorg Chem; 2010 Jan; 49(1):174-87. PubMed ID: 19947643 [TBL] [Abstract][Full Text] [Related]
10. Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum. Sanna D; Bíró L; Buglyó P; Micera G; Garribba E J Inorg Biochem; 2012 Oct; 115():87-99. PubMed ID: 22926028 [TBL] [Abstract][Full Text] [Related]
11. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics. Yasui H; Tamura A; Takino T; Sakurai H J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins. Koleša-Dobravc T; Lodyga-Chruscinska E; Symonowicz M; Sanna D; Meden A; Perdih F; Garribba E Inorg Chem; 2014 Aug; 53(15):7960-76. PubMed ID: 25013935 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the biospeciation of antidiabetic VO(IV) and Zn(II) complexes. Kiss T; Jakusch T; Hollender D; Enyedy EA; Horváth L J Inorg Biochem; 2009 Apr; 103(4):527-35. PubMed ID: 19114286 [TBL] [Abstract][Full Text] [Related]
14. An in vitro study of interactions between insulin-mimetic zinc(II) complexes and selected plasma components. Enyedy EA; Horváth L; Gajda-Schrantz K; Galbács G; Kiss T J Inorg Biochem; 2006 Dec; 100(12):1936-45. PubMed ID: 17034863 [TBL] [Abstract][Full Text] [Related]
15. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845 [TBL] [Abstract][Full Text] [Related]
16. Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug. Sanna D; Ugone V; Micera G; Buglyó P; Bíró L; Garribba E Dalton Trans; 2017 Jul; 46(28):8950-8967. PubMed ID: 28640312 [TBL] [Abstract][Full Text] [Related]
17. Interaction of VO2+ ion with human serum transferrin and albumin. Sanna D; Garribba E; Micera G J Inorg Biochem; 2009 Apr; 103(4):648-55. PubMed ID: 19201482 [TBL] [Abstract][Full Text] [Related]
18. In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato)oxovanadium(IV), studied by electron spin-echo envelope modulation spectroscopy. Fukui K; Fujisawa Y; OhyaNishiguchi H; Kamada H; Sakurai H J Inorg Biochem; 1999; 77(3-4):215-24. PubMed ID: 10643660 [TBL] [Abstract][Full Text] [Related]
19. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives. Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the binding of oxovanadium(IV) to human serum albumin. Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]